Enliven Therapeutics Stock Performance
as on October 31, 2026 at 2:16 pm IST
Day's Low
Day's High
$44.09$45.87
0.36%
Downside
3.66%
Upside
52 Week's Low
52 Week's High
$14.79$62.3266.59%
Downside
40.84%
Upside
Enliven Therapeutics share price movements today
- Previous Close
- $45.08
- Open
- $44.95
- Volume
- 607.9K
- Market Cap
- $3.3B
- Day's Low - High
- $44.09 - $45.87
- 52 Week Low - High
- $14.79 - $62.32
Enliven Therapeutics Historical Returns
- 1 Month Return
- -1.66 %
- 3 Month Return
- -16.44 %
- 1 Year Return
- + 88.07 %
- 3 Year Return
- + 275.98 %
- 5 Year Return
- 0 %
Enliven Therapeutics Stock Fundamentals & Key Indicators
Check Enliven Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.3B
EPS (TTM)
-1.64
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-27.3
Industry PE ratio
-7.01
PEG Ratio
-1.37
EBITDA
-105.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-18.55%
Enliven Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Enliven Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $3.3B | NA | -27.30 | 0.00% | 0.00% | |
| Neutral | $85.5B | -35.47% | -26.84 | -12.57% | 0.00% | |
| StrongBuy | $134.2B | 192.00% | 30.58 | 86.04% | 0.00% | |
| Buy | $83.7B | 27.94% | 19.42 | 84.86% | 0.45% |
Stock Returns calculator for Enliven Therapeutics Stock including INR - Dollar returns
The Enliven Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Enliven Therapeutics investment value today
Current value as on today
₹1,97,561
Returns
₹97,561
(+97.56%)
Returns from Enliven Therapeutics Stock
₹84,606 (+84.61%)
Dollar Impact
₹12,955 (+12.96%)
Analyst Recommendation on Enliven Therapeutics Stock
Based on 10 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 10 analysts, 100% of analysts recommend a 'BUY' rating for Enliven Therapeutics. Average target price of $74.42
Enliven Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Enliven Therapeutics.
What analysts predicted
40.54%UPSIDE
Target Price
$74.42
Current Price
$44.25
Analyzed by
10 Analysts
High
$80
Target
$74.42
Low
$68
Enliven Therapeutics target price $74.42, a slight upside of 40.54% compared to current price of $44.25. According to 10 analysts rating.
Indian Investors' Interest in Enliven Therapeutics Stock
Search interest for Enliven Therapeutics Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Enliven Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Enliven Therapeutics Annual Profit & Loss
All numbers in Millions USD
Enliven Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Enliven Therapeutics Annual Cash Flow
All numbers in Millions USD
Enliven Therapeutics News & Key Events
Today's Timeline - 14 October
Thu, 02:00 AM
-Enliven Therapeutics appoints Kristine Ball to Board of Directors ahead of Phase 3 trial initiation.
Insights on Enliven Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, ELVN stock has moved up by 92.5%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ELVN has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 627.7%
About Enliven Therapeutics
| Organisation | Enliven Therapeutics |
| Headquarters | 6200 Lookout Road, Boulder, CO, 80301, US |
| Industry | Biotechnology |
| CEO | Richard A. Fair |
Key Management of Enliven Therapeutics
Name | Title |
|---|---|
Mr. Samuel S. Kintz M.B.A. | Co-Founder & Head of Pipeline |
Mr. Benjamin Hohl | CFO & Head of Corporate Development |
Dr. Helen Louise Collins M.D. | Chief Medical Officer |
Dr. Joseph P. Lyssikatos Ph.D. | Co-Founder & Research Fellow |
Mr. Anish Patel Pharm.D. | Co-Founder & COO |
Dr. Galya D. Blachman Esq., Ph.D. | Chief Legal Officer & Head of Business Development |
Damiette Smit | Vice President of Clinical Development |
Mr. Richard A. Fair M.B.A. | CEO, President & Director |
FAQs
What is Enliven Therapeutics share price today?
Enliven Therapeutics share price today is $44.25 as on at the close of the market. Enliven Therapeutics share today touched a day high of $45.87 and a low of $44.09.
What is the 52 week high and 52 week low for Enliven Therapeutics share?
Enliven Therapeutics share touched a 52 week high of $62.32 on and a 52 week low of $14.79 on . Enliven Therapeutics stock price today i.e. is closed at $44.25,which is 29.00% down from its 52 week high and 199.29% up from its 52 week low.
What is Enliven Therapeutics's market capitalisation today?
Enliven Therapeutics market capitalisation is $0.00T as on .
How to invest in Enliven Therapeutics Stock (ELVN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Enliven Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Enliven Therapeutics Stock (ELVN) from India?
Indian investors can start investing in Enliven Therapeutics (ELVN) shares with as little as ₹94.94999694824219 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Enliven Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Enliven Therapeutics share’s latest price of $44.25 as on October 31, 2026 at 8:46 am IST, you will get 0.2260 shares of Enliven Therapeutics. Learn more about
fractional shares .